2 active not recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis Brepocitinib PO QD, Placebo PO QD - Uveitis, Posterior, Uveitis, Intermediate | Phase 3 | Active not recruiting | Priovant Therapeutics, Inc. | 371 | 2024-09-11 | 2026-01-12 |
| A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis Baricitinib, Adalimumab - Uveitis | Phase 3 | Active not recruiting | Eli Lilly and Company | 30 | 2019-10-16 | 2026-04-24 |
Uveitis, Intermediate (1) · Uveitis, Posterior (1)
Eye Diseases (2) · Uveal Diseases (2) · Panuveitis (1)
Adalimumab (1) · baricitinib (1)
Eli Lilly and Company (1) · Priovant Therapeutics, Inc. (1)
Germany (2) · Italy (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Czechia (1) · France (1) · Greece (1) · Hungary (1) · Israel (1) · United States (1)
2019 (1)